Navigation Links
SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award
Date:4/30/2009

AMSTERDAM, April 30 /PRNewswire/ -- SynCo Bio Partners B.V. (Amsterdam, The Netherlands), the cGMP manufacturer of clinical and commercial biopharmaceuticals, has won the Vaccine Industry Excellence (ViE) award for Best Contract Manufacturing Organization (CMO) 2009. This award was presented to SynCo at the Washington World Vaccine Congress on the 22nd of April and is a recognition of the excellent work by SynCo's scientists and manufacturing staff on behalf of its clients over the last 9 years.

SynCo was nominated by a panel of judges from the industry and selected over 5 other finalists in the Best CMO category, according to a wide range of criteria including:

    - The range of services provided in niche and core therapeutic
      areas
    - Methods of performance improvement or introduction of new
      services
    - Attention to and quality of relationships with clients
    - Reaching of milestones and final / ongoing outcomes
    - Building and maintaining existing and long term partnerships

Pierre Warffemius, CEO, said 'this award endorses SynCo's aim to be the long term strategic choice of biotechnology companies for the development of production processes and the GMP manufacture of protein, live-microbial, polysaccharide and monoclonal antibody-based biopharmaceuticals."

Issued on behalf of SynCo Bio Partners by De Facto Communications For more information, contact:

About SynCo Bio Partners B.V.

SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with in-depth clinical and commercial production experience with mammalian and microbial systems. This experience has been acquired by developing new production processes for a number of international clients and producing a wide variety of different vaccines, live bacterial products and recombinant proteins in our state-of-the-art, GMP-licensed facilities since inception in 2000.

Focused solely on biopharmaceuticals, SynCo Bio Partners acts as a strategic, long-term partner delivering your product on time and to the highest quality standards. All our staff are committed to exceeding customer expectations and believe that taking a truly collaborative approach to manufacturing is the key to a successful outcome.

http://www.syncobiopartners.com


'/>"/>
SOURCE SynCo Bio Partners B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SynCo Bio Partners Completes Manufacture and Release of ActoGeniX Lead Product for Phase II Clinical Trials
2. Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
3. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
4. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
5. DecisionQ Partners With Thomas Jefferson University to Reveal Insights for Cancer Therapy
6. E&K Scientific Announces Partnership with Sciformatix
7. PRA International Presents Key Budgeting Strategies at 18th Annual CRO Partnerships Conference
8. Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting
9. Brazils top automakers to distribute 2 million copies of the Ethanol Handbook in partnership with the Brazilian Sugarcane Industry Association
10. Childrens Memorial Research Center, Chicago Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
11. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
Breaking Biology News(10 mins):